The Young Law Firm is investigating potential claims against the Board of Directors of Palomar Medical Technologies Inc (“Palomar” or the “Company”) (NasdaqGS:PMTI) concerning the proposed buyout of the Company by Cynosure, Inc. The investigation concerns whether Palomar‘s Board of Directors obtained fair value for the sale of the Company and whether the Board has fulfilled its fiduciary duties to Palomar‘s shareholders in connection with the sale .

Under the terms of the transaction, shareholders will receive $13.65 for each share of Palomar stock they own – $6.825 per share in cash and $6.825 per share in Cynosure common stock (subject to adjustment).

Shareholders have rights. If you own shares of Palomar and would like to learn more about these matters, please contact:

Henry Young Esq.The Young Law FirmToll Free: (888) 452-7252Email: contact@theyounglf.comor visit: www.theyounglf.com/palomar-merger-buyout-shareholder-lawsuit/

The Young Law Firm is a national shareholder litigation firm located outside of Philadelphia, Pa. We protect individual and institutional investors in state and federal courts nationwide. For more information about the firm and class action cases in general, please visit our website: www.theyounglf.com.

Legal Notice: Pursuant to the laws of certain states of the United States this press release may be considered attorney advertising. That The Young Law Firm may have recovered money and other benefits for shareholders in the past does not mean they will do so again. Past performance does not guarantee future results. We are further obliged to tell you that The Young Law Firm may divide legal fees with other law firms and / or seek referral fees in connection with the content of this message.

Grafico Azioni Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Palomar Medical Technologies, Inc. (MM)
Grafico Azioni Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Palomar Medical Technologies, Inc. (MM)